We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$16.6M
AUM Growth
-$9.9B
Cap. Flow
-$129M
Cap. Flow %
-776.34%
Top 10 Hldgs %
44.31%
Holding
282
New
27
Increased
109
Reduced
88
Closed
26

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$56.6M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$49.2M
3
ELV icon
Elevance Health
ELV
+$44.3M
4
AAPL icon
Apple
AAPL
+$41.2M
5
ABT icon
Abbott
ABT
+$38.8M

Sector Composition

Rank Sector Weight
1 Technology 14.69%
2 Financials 13.93%
3 Healthcare 11.89%
4 Communication Services 7.22%
5 Industrials 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOH icon
126
Molina Healthcare
MOH
$10.3B
$25.5K 0.15%
260,700
-149,300
-36% -$13M
DATA
127
DELISTED
Tableau Software, Inc.
DATA
$25.4K 0.15%
259,814
-34,508
-12% -$3.16M
STE icon
128
Steris
STE
$20.9B
$25.2K 0.15%
240,000
-106,384
-31% -$10.7M
ILMN icon
129
Illumina
ILMN
$29.4B
$25.1K 0.15%
92,520
CYBR
130
DELISTED
CyberArk
CYBR
$24.9K 0.15%
394,924
-216,212
-35% -$12.6M
NEWR
131
DELISTED
New Relic, Inc.
NEWR
$24.9K 0.15%
247,074
-286,008
-54% -$25.4M
EVBG
132
DELISTED
Everbridge, Inc. Common Stock
EVBG
$24.3K 0.15%
511,382
-380,741
-43% -$16.2M
ZGNX
133
DELISTED
Zogenix, Inc.
ZGNX
$24.2K 0.15%
548,319
+100,365
+22% +$4.14M
LITE icon
134
Lumentum
LITE
$59.4B
$24.2K 0.15%
417,376
-35,673
-8% -$2.13M
DCPH
135
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$23.4K 0.14%
594,551
+456,851
+332% +$13.4M
LIVN icon
136
LivaNova
LIVN
$4.3B
$23.3K 0.14%
233,400
-128,314
-35% -$11.6M
RNG icon
137
RingCentral
RNG
$4.05B
$23K 0.14%
326,904
-72,213
-18% -$5.17M
EG icon
138
Everest Group
EG
$15.2B
$22.5K 0.14%
97,500
+5,000
+5% +$1.17M
UNH icon
139
UnitedHealth
UNH
$382B
$22.4K 0.13%
91,300
BIIB icon
140
Biogen
BIIB
$29.9B
$21.8K 0.13%
75,000
-15,000
-17% -$4.22M
HRTG icon
141
Heritage Insurance Holdings
HRTG
$842M
$21.7K 0.13%
1,300,000
IRTC icon
142
iRhythm Holdings
IRTC
$3.59B
$21.3K 0.13%
262,011
-60,478
-19% -$4.23M
ALNY icon
143
Alnylam Pharmaceuticals
ALNY
$36.3B
$21.2K 0.13%
215,000
-226,232
-51% -$22.4M
BDX icon
144
Becton Dickinson
BDX
$43.1B
$20.8K 0.13%
89,175
+10,250
+13% +$2.28M
LHCG
145
DELISTED
LHC Group LLC
LHCG
$20.7K 0.12%
+242,000
New +$18.4M
RLI icon
146
RLI Corp
RLI
$5.68B
$20.3K 0.12%
613,800
OLED icon
147
Universal Display
OLED
$3.71B
$20.2K 0.12%
234,767
+53,450
+29% +$5.1M
BMRN icon
148
BioMarin Pharmaceuticals
BMRN
$11.5B
$19.9K 0.12%
211,500
-800
-0.4% -$70.1K
CSCO icon
149
Cisco
CSCO
$450B
$19K 0.11%
441,896
+116,696
+36% +$5.1M
LLY icon
150
Eli Lilly
LLY
$1.07T
$18.9K 0.11%
222,000
+33,000
+17% +$2.71M

Similar funds

Polar Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Polar Capital held 282 positions worth $16.6M, down 100% from $9.92B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Polar Capital withdrew a net $129M in Q2 2018, closing 26 positions and reducing 88 holdings. Its most notable exit was GCI Liberty, Inc. Class A Common Stock (DE), an estimated $37.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Polar Capital opened a new position in Cognizant worth $54.4K.

  • Polar Capital's largest Q2 2018 buy was Cognizant: 688,687 shares worth $54.4K.
  • Polar Capital added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2018, an estimated $68M increase.
  • Polar Capital's biggest Q2 2018 reduction was Merck, cutting an estimated $56.6M.
  • Polar Capital fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q2 2018, selling an estimated $37.7M.
  • Polar Capital's ten largest holdings make up 44% of its $16.6M portfolio in Q2 2018.
  • Polar Capital opened 27 new positions and closed 26 in Q2 2018.
  • Polar Capital's portfolio value fell 100% quarter-over-quarter to $16.6M.

Based on Polar Capital's 13F filing for Q2 2018, filed 14 Aug 2018.